Mast cell leukemia: Difference between revisions

	Mast cell leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Mast cell leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Mast cell leukemia On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mast cell leukemia All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Mast cell leukemia
CDC on Mast cell leukemia
Mast cell leukemia in the news
Blogs on Mast cell leukemia
Directions to Hospitals Treating Mast cell leukemia
Risk calculators and risk factors for Mast cell leukemia

VisualWikitext

Latest revision as of 12:08, 17 August 2020

For patient information click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2],Nawal Muazam M.D.[3]

Synonyms and keywords: Mast cell blood cancer; Mast cell cancer; Mastocyte cancer; Mastocyte leukemia; Malignant mastocytosis; Mastocyte blood cancer; Basophilic leukemia

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mast cell leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Treatment

Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case#1

References

Template:WikiDoc Sources

@@ Line 3: / Line 3: @@
 '''For patient information click [[{{PAGENAME}} (patient information)|here]]'''.
-{{CMG}}; {{AE}}{{NM}}
+{{CMG}}; {{AE}} {{S.G.}},{{NM}}
 {{SK}} Mast cell blood cancer;  Mast cell cancer; Mastocyte cancer; Mastocyte leukemia; Malignant mastocytosis; Mastocyte blood cancer; Basophilic leukemia
@@ Line 26: / Line 26: @@
 ==[[Mast cell leukemia natural history, complications, and prognosis|Natural History, Complications, and Prognosis]]==
-{{CMG}}; {{AE}} {{S.G.}}
-==Overview==
-If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
-OR
-Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
-OR
-Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
-==Natural History, Complications, and Prognosis==
-===Natural History===
-*The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
-*The symptoms of (disease name) typically develop ___ years after exposure to ___.
-*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
-===Complications===
-*Common complications of [disease name] include:
-**[Complication 1]
-**[Complication 2]
-**[Complication 3]
-===Prognosis===
-*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
-*Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
-*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
-*[Subtype of disease/malignancy] is associated with the most favorable prognosis.
-*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
-==References==
-{{Reflist|2}}
-{{WH}}
-{{WS}}
-[[Category: (name of the system)]]
-==Overview==
-If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
-OR
-Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
-OR
-Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
-==Natural History, Complications, and Prognosis==
-===Natural History===
-*The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
-*The symptoms of (disease name) typically develop ___ years after exposure to ___.
-*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
-===Complications===
-*Common complications of [disease name] include:
-**[Complication 1]
-**[Complication 2]
-**[Complication 3]
-===Prognosis===
-*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
-*Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
-*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
-*[Subtype of disease/malignancy] is associated with the most favorable prognosis.
-*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
-==References==
-{{Reflist|2}}
-{{WH}}
-{{WS}}
-[[Category: (name of the system)]]
 ==Diagnosis==
 [[Mast cell leukemia staging|Staging]] | [[Mast cell leukemia history and symptoms|History and Symptoms]] | [[Mast cell leukemia physical examination|Physical Examination]] | [[Mast cell leukemia laboratory findings|Laboratory Findings]] | [[Mast cell leukemia x ray findings|Chest X Ray]] | [[Mast cell leukemia CT|CT]] | [[Mast cell leukemia MRI|MRI]]| [[Mast cell leukemia other imaging findings|Other Imaging Findings]] | [[Mast cell leukemia other diagnostic studies|Other Diagnostic Studies]]